Web Analytics
MARKETS
S&P 500 7,811.54+46.18 · +0.59%
Nasdaq 27,366.17+172.83 · +0.64%
Silver 61.05+1.62 · +2.73%
Bitcoin 82,997.14+442.16 · +0.54%
WTI Crude 91.85+0.36 · +0.39%
US 10Y 5.24+0.01 · +0.25%
News

D.E. Shaw Buys $912 Million of SpaceX, Halves Broadcom

The quant firm's latest quarterly disclosure pairs a $912 million SpaceX position with a 58% cut to Broadcom, a swap of listed AI chip exposure for a private space holding.

Simon Prescott 7 min read
Dramatic night view of an industrial landscape in Rotterdam, Netherlands.

D.E. Shaw disclosed a $912 million stake in SpaceX and a 58% reduction in its Broadcom position in the same quarterly filing.

D.E. Shaw used one quarterly filing to do two very different things: it disclosed a $912 million stake in SpaceX, and it cut its holding in Broadcom Inc. (NASDAQ: AVGO) by 58%. Taken separately, each is a large position change at a firm that runs money in size. Taken together, they describe a rotation — out of the most heavily owned listed exposure to artificial intelligence hardware, and into a privately held company that most institutional portfolios cannot access at all.

The pairing is what makes the filing worth reading closely. Selling more than half of a chip position after a sustained run is ordinary risk management. Redeploying into a private space company at close to a billion dollars is not. The disclosure was reported by 24/7 Wall St.

Why a private company shows up in a hedge fund disclosure at all

Quarterly 13F filings are built for listed equities. A private company like SpaceX does not have a public ticker, does not trade continuously, and is not marked by an exchange at the close. When a stake of this kind surfaces in a manager's disclosures, it typically arrives through a valuation the manager itself has struck — based on the last round it participated in, a secondary transaction, or an internal model — rather than a market print anyone else can verify.

That distinction matters for anyone reading the $912 million figure. It is a carrying value, not a quote. It will not move day to day the way the rest of the book does, and it cannot be exited by hitting a bid. For a firm whose reputation is built on systematic, liquid strategies, that is an unusual asset to carry at this size, and it implies a holding period measured in years rather than quarters.

It also tells you something about how the private market for pre-IPO stakes has matured. Positions of this scale in a company that has never listed used to sit with venture funds and sovereign wealth vehicles. They now sit alongside listed equity books at multi-strategy firms, which means the line between public-market investing and late-stage private investing is blurrier than the filing categories suggest.

The Broadcom side of the trade

Broadcom closed at $368.45 on Friday, 21 August 2026, up 1.21% on the session, with a day range of $365.05 to $375.13 against a prior close of $364.03. The stock has been one of the primary listed vehicles for AI infrastructure exposure, sitting alongside the merchant GPU names as a supplier of custom accelerators and networking silicon to hyperscale data centre operators.

Cutting 58% of that position is a decisive move, but it is not the same thing as calling a top. A 58% reduction leaves 42% of the original stake in place — the firm is still long, just materially less so. That is the profile of a manager trimming a position that had grown too large relative to the rest of the portfolio, which is what happens mechanically when a holding appreciates faster than everything around it.

The timing question the filing cannot answer is where inside the quarter the selling happened. A 13F is a snapshot of holdings at quarter end, not a trade blotter. The firm may have sold into strength early or reduced late; the disclosure treats both identically. Anyone trying to reverse-engineer a price level from the position change is reading more into the document than it contains.

What the swap says about where the risk is thought to be

The cleanest reading of the two moves together is a shift in the shape of the AI trade, not an exit from it. Listed semiconductor names carry the full weight of the market's expectations for data centre capital spending, and they reprice violently when those expectations wobble. A private stake in a launch and satellite business carries a different set of risks entirely — execution, regulation, capital intensity — and, crucially, does not mark against the same crowd.

The cleanest reading of the two moves together is a shift in the shape of the AI trade, not an exit from it.

That is a diversification argument as much as a directional one. A fund that has made money in AI hardware and wants to keep growth exposure without doubling down on the same factor has limited options in listed markets, where the correlated names are correlated precisely because everyone owns them. Moving capital into an unlisted asset breaks that correlation by construction.

The broader market backdrop was constructive on the last trading day before the filing drew attention. The S&P 500 tracker (SPY) closed at $765.72, up 0.41%, and the Nasdaq 100 tracker (QQQ) finished at $713.44, up 0.35% — both firm, with the Dow tracker (DIA) leading at $532.22, up 0.89%. This was not a manager cutting chip exposure into a broad risk-off tape.

What to watch from here

Three things will tell readers whether this filing marked a genuine turn or a one-quarter rebalance.

  • The next filing. If the remaining Broadcom stake shrinks further, the trim becomes a trend. If it stabilises or grows back, the cut was position sizing.
  • How the SpaceX stake is carried. Any change in the disclosed value, absent new purchases, is a revaluation — and revaluations of private holdings are the closest thing outsiders get to a mark on the private space market.
  • Whether other large managers follow. One firm's private-market allocation is idiosyncratic. Several showing similar stakes in the same quarter would suggest a structural reallocation away from crowded listed AI exposure.

For retail investors, the practical takeaway is narrower than the headline suggests. The Broadcom trim is replicable; the SpaceX position is not, and no listed proxy reproduces it. What the filing offers is a read on how one large, quantitatively driven allocator is thinking about concentration risk in the AI complex — reducing where the crowd is thickest, and paying up for exposure the crowd cannot buy.

It is also a reminder of what 13F disclosures are and are not. They arrive with a lag, they show holdings rather than intentions, and they say nothing about hedges, options overlays or short positions that might sit against a long stake. A 58% reduction in a filing is a fact. The reason behind it is inference, and it should be labelled as such.

Key facts

  • SpaceX stake disclosed: $912 million
  • Broadcom position change: Cut by 58%
  • AVGO last close: $368.45, +1.21% (21 Aug 2026, 20:00 GMT)
  • Filing: Both moves in the same quarterly disclosure

Frequently asked questions

How large is D.E. Shaw's SpaceX stake?

D.E. Shaw disclosed a SpaceX stake valued at $912 million in its latest quarterly filing. Because SpaceX is a private company with no exchange listing, that figure is a carrying value struck by the manager rather than a market price. It will not move with daily trading and cannot be exited by selling into an order book.

How much of its Broadcom position did D.E. Shaw sell?

The firm cut its Broadcom holding by 58% during the quarter covered by the filing. That leaves the remaining 42% of the original position still in place, so the manager is still long the stock, just at materially reduced size. The filing does not disclose when inside the quarter the selling took place.

Where did Broadcom shares last close?

Broadcom closed at $368.45 on Friday, 21 August 2026, a gain of 1.21% on the session against a prior close of $364.03. The stock traded in a range of $365.05 to $375.13 that day. Markets were closed at the time of writing, so this is the most recent traded price.

Why can a hedge fund hold a private company like SpaceX?

Late-stage private companies increasingly sell shares to institutional buyers through funding rounds and secondary transactions, rather than waiting for an IPO. Multi-strategy firms with long-dated capital can hold those stakes alongside listed equities, though the positions are illiquid and valued internally rather than by an exchange.

Does the trim mean D.E. Shaw is bearish on AI chips?

The filing does not say. A 58% reduction still leaves a substantial long position, and trims of that kind often reflect position sizing after a holding has appreciated faster than the rest of a portfolio. Reading a directional view into a 13F snapshot is inference, not reported fact.

Can retail investors replicate this trade?

Only half of it. Broadcom is listed and freely tradable, so reducing exposure is straightforward. The SpaceX stake is not available to public-market investors — there is no listed ticker and no exchange-traded fund that provides equivalent direct exposure to the private company's equity.

Sources

Photo: A P · Pexels Licence — source

Filed under News

More on News

See all →